Eledon Pharmaceuticals
ELDN
ELDN
16 hedge funds and large institutions have $5.43M invested in Eledon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less capital invested
Capital invested by funds: $18.2M → $5.43M (-$12.8M)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$121K | |
| 2 | +$8.01K | |
| 3 | +$2K | |
| 4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$235 |
Top Sellers
| 1 | -$1.48M | |
| 2 | -$421K | |
| 3 | -$149K | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$91K |
| 5 |
D.E. Shaw & Co
New York
|
-$58K |